📣 VC round data is live. Check it out!
- Public Comps
- AMA Corp
AMA Corp Valuation Multiples
Discover revenue and EBITDA valuation multiples for AMA Corp and similar public comparables like Pheton Holdings, Carmat, SpectraCure, Bio-Gate and more.
AMA Corp Overview
About AMA Corp
AMA Corp PLC specializes in the development of remote assistance, inspection, and training solutions involving connected glasses, a dedicated smartphone, and external video sources such as webcams, thermographic cameras, endoscopes, microscopes, and others. Geographically the company operates in Europe, which includes subsidiaries in France, Germany, the UK, Romania, Italy and Spain and which invoice customers in Europe; North America, which includes subsidiaries in the United States and Canada and which invoice customers in the North American area; and lastly Asia, which includes subsidiaries in Hong Kong, Shanghai and Japan and which invoice customers in the Asia area.
Founded
2016
HQ

Employees
40
Website
Financials (FY)
EV
$8M
Valuation Multiples
Start free trialAMA Corp Financials
AMA Corp reported last fiscal year revenue of $2M and negative EBITDA of ($6M).
In the same fiscal year, AMA Corp generated $2M in gross profit, ($6M) in EBITDA losses, and had net loss of ($7M).
Revenue (LTM)
AMA Corp P&L
In the most recent fiscal year, AMA Corp reported revenue of $2M and EBITDA of ($6M).
AMA Corp is unprofitable as of last fiscal year, with gross margin of 71%, EBITDA margin of (251%), and net margin of (285%).
Financial data powered by Morningstar, Inc.
AMA Corp Stock Performance
AMA Corp has current market cap of $7M, and enterprise value of $8M.
Market Cap Evolution
AMA Corp's stock price is $0.14.
AMA Corp share price increased by 8.9% in the last 30 days, and decreased by 49.2% in the last year.
AMA Corp has an EPS (earnings per share) of $-0.12.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $7M | 9.0% | 8.9% | -8.0% | -49.2% | $-0.12 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAMA Corp Valuation Multiples
AMA Corp trades at 3.6x EV/Revenue multiple, and (1.4x) EV/EBITDA.
EV / Revenue (LTM)
AMA Corp Financial Valuation Multiples
As of June 3, 2026, AMA Corp has market cap of $7M and EV of $8M.
AMA Corp has a P/E ratio of (1.1x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AMA Corp Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


AMA Corp Margins & Growth Rates
In the most recent fiscal year, AMA Corp reported gross margin of 71%, EBITDA margin of (251%), and net margin of (285%).
AMA Corp Margins
AMA Corp Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
AMA Corp Operational KPIs
AMA Corp's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
AMA Corp Competitors
AMA Corp competitors include Pheton Holdings, Carmat, SpectraCure, Bio-Gate, enVVeno Medical, Zynex, Redsense Medical, PharmaCyte Biotech, Qlife Holding and Synthetic MR.
Most AMA Corp public comparables operate across Healthcare Software, IoT, Medical Devices, Wearables, B2B SaaS, DeepTech, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| - | - | - | - | |||
| - | - | (2.3x) | - | |||
| 0.8x | 0.8x | (6.7x) | (11.5x) | |||
| - | - | 0.8x | - | |||
| - | - | - | - | |||
| 2.3x | - | (8.3x) | - | |||
| - | - | 2.6x | - | |||
This data is available for Pro users. Sign up to see all AMA Corp competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AMA Corp
| When was AMA Corp founded? | AMA Corp was founded in 2016. |
| Where is AMA Corp headquartered? | AMA Corp is headquartered in France. |
| How many employees does AMA Corp have? | As of today, AMA Corp has over 40 employees. |
| Is AMA Corp publicly listed? | Yes, AMA Corp is a public company listed on Euronext Paris. |
| What is the stock symbol of AMA Corp? | AMA Corp trades under ALAMA ticker. |
| When did AMA Corp go public? | AMA Corp went public in 2021. |
| Who are competitors of AMA Corp? | AMA Corp main competitors include Pheton Holdings, Carmat, SpectraCure, Bio-Gate, enVVeno Medical, Zynex, Redsense Medical, PharmaCyte Biotech, Qlife Holding, Synthetic MR. |
| What is the current market cap of AMA Corp? | AMA Corp's current market cap is $7M. |
| What is the current revenue of AMA Corp? | AMA Corp's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of AMA Corp? | Current revenue multiple of AMA Corp is 3.6x. |
| Is AMA Corp profitable? | No, AMA Corp is not profitable. |
| How many companies AMA Corp has acquired to date? | AMA Corp hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies AMA Corp has invested to date? | AMA Corp hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to AMA Corp
Lists including AMA Corp
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.